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A key question in development is how pluripotent progenitors are progressively restricted to acquire specific cell fates. Here we investigate how
embryonic blastomeres in C. elegans develop into foregut (pharynx) cells in response to the selector gene PHA-4/FoxA. When pha-4 is removed
from pharyngeal precursors, they exhibit two alternative responses. Before late-gastrulation (8E stage), these cells lose their pharyngeal identity and
acquire an alternative fate such as ectoderm (Specification stage). After the Specification stage, mutant cells develop into aberrant pharyngeal cells
(Morphogenesis/Differentiation stage). Two lines of evidence suggest that the Specification stage depends on transcriptional repression of ectodermal
genes by pha-4. First, pha-4 exhibits strong synthetic phenotypes with the B class synMuv gene tam-1 (Tandam Array expression Modifier 1) and
with amediator of transcriptional repression, the NuRD complex (NUcleosome Remodeling and histone Deacetylase). Second, pha-4 associates with
the promoter of the ectodermal regulator lin-26 and is required to repress lin-26 expression. We propose that restriction of early blastomeres to the
pharyngeal fate depends on both repression of ectodermal genes and activation of pharyngeal genes by PHA-4.
Published by Elsevier Inc.Keywords: Embryogenesis; Mi-2; Organogenesis; Pharynx; SynMuv; Selector geneIntroduction
Embryonic progenitor cells are born pluripotent, but over
time their developmental choices become restricted until
ultimately they, or their descendants, differentiate into special-
ized cell types. For example, cells derived from a mammalian
blastula can be induced to differentiate into virtually any cell
type, whereas only a limited number of cell fate choices are
available to fetal cells (Tiedemann et al., 2001). The transition
from naïve precursor towards the differentiated state is
characterized by sequential waves of gene expression that are
determined by regulatory transcription factors. A key question
is how transcriptional circuitry dictates developmental compe-
tence, cell fate specification and ultimately differentiation. Here
we investigate this question by studying development of the C.
elegans pharynx and the specification of early blastomeres to a
pharyngeal fate.⁎ Corresponding author. Fax: +1 801 585 1980.
E-mail address: susan.mango@hci.utah.edu (S.E. Mango).
0012-1606/$ - see front matter. Published by Elsevier Inc.
doi:10.1016/j.ydbio.2006.11.042Two lines of evidence suggest that embryonic cells in C.
elegans are pluripotent at the beginning of gastrulation at the 2E
stage (equivalent to 16–44 cells; embryos are staged by the
number of endodermal or E cells). First, at the 2E stage and
earlier, individual blastomeres contribute to multiple cell types,
as revealed by the C. elegans cell lineage. For example the MSp
blastomere generates both pharyngeal cells and body wall
muscles (Sulston et al., 1983). One cell division later (4E stage,
50–100 cells), many cells give rise to descendants that con-
tribute to only a single tissue or organ (Labouesse and Mango,
1999). Second, blastomeres at the 2E stage can adopt alternate
fates in response to forced ubiquitous expression of heterolo-
gous cell fate regulators (Fukushige and Krause, 2005; Horner
et al., 1998; Labouesse and Mango, 1999; Zhu et al., 1998). For
example, ectopic expression of the midgut regulator end-1
transforms all early embryonic cells to a midgut fate (Zhu et al.,
1998). However, previous studies suggest that some time
between the 4–10E stages, early blastomeres can no longer
adopt alternate fates when challenged with an ectopic cell fate
regulator (Fukushige and Krause, 2005; Horner et al., 1998;
Labouesse and Mango, 1999; Zhu et al., 1998). These obser-
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the 10E stage.
An appealing candidate to contribute to cell fate restriction is
the selector gene pha-4. pha-4 encodes a FoxA transcription
factor that is conserved in all metazoans (Mango et al., 1994a;
Zaret, 1999). pha-4 is essential to establish pharyngeal cells and
in the absence of pha-4, pharyngeal cells develop into non-
pharyngeal cell types such as ectoderm (Horner et al., 1998).
Strikingly, pha-4 expression initiates at the 2E stage and
continues to be expressed throughout the life of the worm.
However, the absence of a conditional pha-4 allele made it
impossible previously to investigate when pha-4 functions to
control cell fate.
Recent studies in other organisms have revealed that selector
genes can control cell fates by functioning as both activators and
repressors (Mann and Carroll, 2002). For example, the
transcription factor GATA-1 both activates and represses target
genes to promote the generation of diverse hematopoietic cell
types (Ferreira et al., 2005). In C. elegans, pha-4 is known to
activate expression of a wide array of pharyngeal genes (Gaudet
and Mango, 2002). Similarly, FoxA proteins in other organisms
function as transcriptional activators during foregut develop-
ment (Zaret, 1999). There are two experiments that suggest
pha-4may also restrict cells to the pharyngeal fate by repressing
ectodermal development. First, in the absence of pha-4,
pharyngeal precursors transfate to ectodermal cell types that
express the zinc finger protein LIN-26 (Horner et al., 1998;
Mango et al., 1994a). Second, expression of ectopic PHA-4
confers pharyngeal identity to embryonic blastomeres at the
expense of LIN-26+ ectoderm (Horner et al., 1998). These
observations lead to the intriguing hypothesis that pha-4 might
control cell fate by repressing ectodermal gene expression
directly. Alternatively, pha-4 could function indirectly, by ac-
tivating a repressor.
The cell fate regulators, the synthetic multivulval (synMuv)
genes, include components of the Nucleosome Remodeling
Deacetylase (NuRD) transcriptional repressor complex. Single
mutants in either of the genetically redundant synMuv A and B
classes exhibit normal vulval development, whereas double
mutants develop ectopic vulva and exhibit a multivulva (Muv)
phenotype (Fay and Han, 2000). Many synMuv genes are
conserved in vertebrates, including homologs of retinoblastoma
(RB)/lin-35, and E2F and DP transcription factors, efl-1 and
dpl-1. In addition, three synMuv genes, Mi-2/chd-4, RbAp48/
lin-53 and, HDAC/hda-1, are members of the predicted C.
elegans NuRD complex, which has histone deacetylase and
chromatin remodeling activities (Bowen et al., 2004; Solari and
Ahringer, 2000). C. elegans orthologues of NuRD complex
components include the SNF2 chromatin remodeling ATPases
Mi-2/chd-3 and Mi-2/chd-4, the metastasis-associated proteins
MTA/egr-1 and MTA/egl-27, the histone binding protein
RbAp48/lin-53, the histone deacetylase HDAC/hda-1, and the
zinc-finger protein p66/dpc-66 (Ahringer, 2000). Thus, the
synMuv pathway comprises multiple regulators of transcription,
including components of the NuRD complex.
In C. elegans, there are two examples where synMuv and
NuRD factors restrict the cell fate potential of precursor cells byrepressing alternate cell fates. In the vulva, NuRD and synMuv
genes inhibit vulval precursor cells from adopting vulval fates
(Cui et al., 2006; Solari and Ahringer, 2000; von Zelewsky et
al., 2000). As a result, vulval precursor cells differentiate as
epidermis and fuse with the surrounding epithelium. synMuv
and NuRD genes also promote development of somatic cells by
preventing expression of germline genes in the soma (Unha-
vaithaya et al., 2002; Wang et al., 2005). A critical question is
how the synMuv genes distinguish these alternative fates. In
particular, what genes are targeted and what transcription
factors interact with synMuv genes?
In this study we investigate the molecular mechanisms of
pharyngeal cell fate restriction. Our data reveal that pha-4
controls lineage restriction of pharyngeal cells, and is an
important regulator of both the Specification stage and the
Morphogenesis/Differentiation stage. Furthermore, we show
that specification of the pharyngeal precursors is dependent on
pha-4 co-operating with the B class synMuv gene tam-1 and
other synMuv genes including NuRD components. Finally, we
present evidence that PHA-4 directly represses expression of
ectodermal genes in pharyngeal cells, arguing that restriction to
pharyngeal fate depends on both repression of ectodermal genes
and activation of pharyngeal genes by PHA-4. An appealing
possibility is that FoxA factors in other organisms may also
have dual transcriptional roles as activators and repressors.
Materials and methods
Strains
Strains were maintained according to Brenner (Brenner, 1974), maintained
at 20 °C, and were provided by Caenorhabditis Genetics Center, unless stated
otherwise. Bristol N2 was used as the wild-type strain. The following mutations
were used LGI: unc-13(e1091), lin-35(n745), dpy-5(e61), lin-53(n833), smg-1
(cc546), smg-1(r861); LGII: dpl-1(n2994), egl-27(n170), lin-8(n111), lin-38
(n751), lin-56(n2738); LGIII: lin-9(n112), lin-13(n770), lin-36(n766), lin-37
(n758), lin-52(n771); LGIV: cha-1(p1182), lin-54(n2231); LGV: chd-4(ar113),
dpy-11(e224), efl-1(se1), fog-2(q71), egr-1(ku285), pha-4(q490), pha-4(q500),
pha-4(zu225), rol-9(sc148), stu-3(q265), tam-1(cc567), unc-46(e177), unc-76
(e911); LGX: chd3(eh4), lin-15(n767). Experiments with tam-1(cc567) were
carried out at restrictive temperature (25 °C) where it behaves as a predicted null
(Hsieh et al., 1999), and maintained at permissive temperature (15 °C).
Temperature sensitive pha-4 strains were maintained at 24 °C, restrictive
temperature is 15 °C; smg-1(cc546ts);pha-4(zu225) [referred to as pha-4(ts)]
and smg-1(r861);pha-4(zu225) [referred to as smg-1(0);pha-4] are sensitized to
pharynx phenotypes at 24° (Gaudet and Mango, 2002; Kaltenbach et al., 2005).
pha-4 null: lethal progeny from fog-2(q71) pha-4(q490)/stu-3(q265). elt-3∷gfp
(JG5) was a gift from Jim McGhee (Gilleard and McGhee, 2001).
DNA constructs
pha-4∷yfp (SEM692) was made from a pha-4 genomic clone (Azzaria et
al., 1996) encompassing 7076 nucleotides upstream of the first ATG to 1062
nucleotides 3′ of the stop site. An additional 1907 nucleotides 3′ were PCR
amplified from N2 genomic DNA and added to create a clone spanning to
2969 nucleotides 3′ of the stop site. The resulting ∼16.7 kb genomic
sequence has previously been shown to rescue pha-4 null mutants (Horner et
al., 1998). The pha-4 stop site was PCR mutagenized, and SnaB1 and Avr2
restriction sites were introduced in its place. YFP was PCR amplified from
pPD136.64 (a gift from A. Fire) with SnaB1 and Avr2 sites added to the
ends. SnaB1/Avr2 YFP was inserted into the mutagenized pha-4 clone. The
pha-4 RNAi plasmid (bSEM 865) consists of a 1.5 kb pha-4 fragment
cloned from N2 cDNA using the following primers: pha-4 AttB1 fw:5′-
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ggggaccactttgtacaagaaagctgggttttataggttggcggccgagtt-3′. The PCR product
was inserted into pDONORdT7 (Reddien et al., 2005) using a BP reaction
(Invitrogen) to create RNAi entry clones. The clones were transformed into
E. coli strain HT115. The nuclear spot target was CISg from the lin-26
promoter (Landmann et al., 2004). The 0.9 kb fragment was PCR amplified
from genomic N2 DNA using the following primers CISg fw:5′-
ggttgcatgcccttgactcttgat-3′, CISg rv: 5′-aatggcgacgattgatgggattgg-3′. A second
target was made utilizing a PCR fusion based approach (Hobert, 2002),
joining together PCR fragments with mutagenized FoxA sites (TRTTKRY,
mutagenized sites underlined). Primers: FoxA proximal fw:5′-attcacggatact-
gatcaatttca-3′, FoxA mid fw:5′-gttcacgagcacagcgccccctag-3′, FoxA distal
fw:5′-tacccgtctgacggttgtcgctcc-3′. The PCR products were cloned into pCR
2.1-TOPO (Invitrogen) and sequenced to verify that only FoxA sites were
mutagenized.
Immunostaining
In situ antibody staining for α-PHA-4 (pharynx, midgut, hindgut)
(Kaltenbach et al., 2005), α-LIN-26 (early ectoderm) (Labouesse et al., 1996),
α-intermediate filament (IF, marginal cells) (Pruss et al., 1981), was performed
as described (Mango et al., 1994a,b) with the following changes. Embryos were
fixed with 2% paraformaldehyde, permeabilized by freeze-crack, then
submersed in ice-cold methanol for 5 min. Antibody staining for MH27
(adherens junctions) (Francis and Waterston, 1991), 3NB12 (early pharyngeal
muscle) (Priess and Thomson, 1987), 9.2.1 (late pharyngeal muscle) (Miller et
al., 1983), was performed as described (Portereiko and Mango, 2001). Briefly,
following freeze-crack, embryos were fixed with ice-cold methanol, then ice-
cold acetone for 5 min, and rehydrated for 30 s. each in 90%, 60%, 30%, and
10% acetone in water. Mounting medium consisted of 50% glycerol in PBS with
DAPI and p-phenylenediamine. Samples were analyzed with a Zeiss LSM510
confocal microscope equipped with LSM software.
Embryo manipulation
Temperature shifts: 2 and 4-cell embryos were dissected from gravid smg-1
(ts);pha-4(q500) hermaphrodites into M9 (Brenner, 1974) and transferred
quickly to 100 μl M9 in a PCR tube. Permissive to restrictive temperature shift:
Embryos were incubated at 24 °C for 60 min (2E), 110 min (4E), 3 h (8E), 4.5 h
(16E) (at least 90% of embryos were at the appropriate stage at the indicated
time), the temperature was ramped at 0.1 °C/ s to 15 °C and embryos incubated
from 8 h to overnight until they reached 2-to 3-fold stages. Restrictive to
permissive temperature shift: Embryos were incubated at 15 °C for 2 h (2E
stage), 3 h (4E), 5 h (8E), 8 h (16E), the temperature was ramped at 0.1 °C/ s to
24 °C and embryos incubated 8–12 h until they reached the 2-to 3-fold stages.
Shifting pha-4(ts) to restrictive temperature reduces PHA-4 expression
(Kaltenbach et al., 2005). Heat shock: 2 and 4-cell embryos were dissected
from gravid hermaphrodites into M9 and transferred quickly to 100 μl M9 in a
PCR tube. Embryos were incubated at 20 °C for 75 min (2E stage), 2 h 15 min
(4E), 3 h 45 min (8E), 5 h (16E), the temperature was then ramped at 0.1 °C/ s up
to 33 °C, and the embryos incubated at 33 °C for 30 min, temperature was
ramped down to 20 °C, and embryos incubated from 8 h to overnight until wild-
type animals reach the 3-fold stage.
RNA interference
RNAi by microinjection: RNAi by microinjection of PHA-4 interacting
proteins was performed as previously described (Fire et al., 1998) with the
following modifications. RNAi clones were obtained in the pL4440-dest-RNAi
vector (Rual et al., 2004) and in vitro transcribed with T7 polymerase using
Ampliscribe RNA transcription kit (Epicentre). RNA transcriptions were
purified on RNeasy columns (Qiagen), diluted to 0.5 to 1 ng/μl, and injected
into smg-1(r861); pha-4(zu225) young adults. After 12 h, injected worms were
moved to fresh plates; progeny were scored for phenotypes at intervals 24–48 h
post-injection. Feeding RNAi: Bacterial feeding RNAi clones, except gfp, and
pha-4, were from the Ahringer/Geneservice Ltd. library of 16,757 clones
(Fraser et al., 2000; Kamath et al., 2003). Clones were confirmed by restrictionenzyme digest. Feeding RNAi was performed as described previously (Kamath
et al., 2001) with the following modifications: Bacteria were grown 12–16 h in
LB with 50 μg/ml ampicillin (Sigma) at 37 °C, 5 ml cultures were spun at
2,000 rpm for 7 min, 4.5 ml of supernatant was removed, the remaining pellet
and supernatant were resuspended, and 50 μl plated onto 6 cm NGM plates with
5 mM IPTG (Fisher Scientific) and 25 μg/μl Carbenicillin (Sigma). Plates dried
at 37 °C for 4–6 h. 4–6 L4 hermaphrodites were placed onto cooled plates
(20 °C, or appropriate temperature), moved to a new RNAi plate after 1 day, and
moved again after laying eggs for 1 day. Embryos developed for 1–2 days before
dead embryos and L1s were scored. Effectiveness of synMuvA, and synMuvB
RNAi were verified by ability to induce Muv phenotypes in lin-37(n758) or lin-
15A(n767) strains, respectively. Weak pha-4(RNAi): Bacteria expressing pha-4
(bSEM 865) or gfp (pPD128.110, a gift from A. Fire) RNAi cultures were
grown overnight as described above, except that pha-4 clones were grown in LB
with 50 ng/μl kanamycin. pha-4 and gfp-expressing cultures were mixed at a
ratio of 1:10–1:20 prior to spinning at 2000 rpm. Resuspended bacteria were
plated onto NGM plates with 1 mM IPTG. Ratios that generated 10–51%
lethality of N2 worms were used for the enhancement assays.
Enhancement assays
Candidate PHA-4 interactor(RNAi). Double-stranded RNA was injected
into 10 smg-1(r861);pha-4(zu225) [smg-1(0);pha-4] young adults, and
progeny were examined for phenotypes. Progeny were scored for lethality,
sterility, and slow growth. Results were compared to published data in wild-
type (N2 or rrf-3) worms (Kamath et al., 2003; Simmer et al., 2003). Weak
pha-4(RNAi) on test worm strains. Diluted pha-4(RNAi) was fed to WT or test
(synMuv, NuRD mutants) strains and percent lethal progeny (eggs, L1s) was
scored. At least 50 animals were scored for each of the 3 trials performed for
each test strain. The fold difference was calculated by dividing % lethal in the
test strain by % lethal in controls. A 2×2 Fisher's exact test (Agresti, 2002)
was used to identify trials with significant enhancement of the lethal
phenotype (p<0.05). A test strain was characterized as an enhancer if
calculated p-value was <0.05 and the fold-enhancement was >1 for each trial.
Each strain displayed a low “background” lethality (<5%) when fed control
(gfp) double-stranded RNA, except egr-1(ku285) which had a background
lethality of 20% (n>50, 3 trials). In the case of egr-1(ku285), 20% was
subtracted from “test strain weak pha-4(RNAi)” lethality value before
calculating statistical significance and fold-enhancement (Supplementary
Table 3). We note that although genetic analysis demonstrates tam-1 is a
pha-4 enhancer, fold enhancement in RNAi experiments is often less than
2-fold (For example, Supplementary Table 3, experiments 5, 8 show
enhancement at 1.3-fold). We have the greatest confidence in genes that like
tam-1, reproducibly enhanced pha-4 with statistical significance, and therefore
only these were scored as enhancers. test(RNAi) on pha-4 strain. synMuv,
NuRD RNAi was fed to control smg-1(ts) and smg-1(ts);pha-4(zu225) at
permissive temperature (24°). Control experiments confirmed the ability of
synMuv(RNAi) to produce a Muv phenotype in the appropriate synMuv
background strain lin-15(n767) or lin-37(n758). Because smg-1(ts);pha-4 had
an average background of 5% lethality when fed control (gfp) dsRNA (n>100,
3 trials), statistical significance and fold difference were calculated compared
to a baseline of 5% lethality. test(RNAi) displayed low background lethality
(<5%) when fed to control strain (n>50, z3 trials), except lin-53(RNAi) and
ubc-9(RNAi) which had an average of 82% and 17% background lethality,
respectively (n>50, z3 trials). lin-53(RNAi) and ubc-9(RNAi) background
lethality [“control strain; test(RNAi)” value] was subtracted from “smg(ts);
pha-4;test(RNAi)” lethality value before calculating statistical significance and
fold-enhancement (Supplementary Table 4).
Nuclear spot assay
Microinjections: Transgenic lines were as follows: no target control
(SM1413, SM1414), lin-26 CISg target (SM1398, SM1420), lin-26 CISg target
with mutagenized FoxA sites (SM1455, SM1459). SM1413, SM1414 were
created by injecting cha-1(p1182) worms with Xho1-linearized pha-4∷yfp
plasmid (SEM691) (1 ng/μl), H2A.Zpromoter∷CFP∷LacI PCR product
(Updike and Mango, 2006) (4 ng/μl), an Sph1/Kpn1 fragment from lacO
multimeric plasmid pSV2-dhfr-8.23 (4.5 ng/μl) (Straight et al., 1996), cha-1
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sheared herring sperm DNA to make 100 ng/μl total DNA. SM1398, SM1420
were created by injecting lin-26 CISg target PCR product (10 ng/μl), and
SM1455 and SM1459 were created by injecting lin-26 CISg mutagenized PCR
product (10 ng/μl) in addition to components listed for SM1413 and SM1414.
PHA-4∷YFP rescues pharyngeal cells in pha-4 null animals to the same extent
as a pha-4 genomic clone (both rescue partially). Analysis: Nuclear spot assays
were performed as described previously (Carmi et al., 1998; Gonzalez-
Serricchio and Sternberg, 2006; Kaltenbach et al., 2000; Updike and Mango,
2006). The following modifications were made: Images were acquired from live
embryos using a Leica DM RXE confocal microscope with LCS software. A
multitrack setting was used to acquire separate CFP and YFP images from three
random slices through the pharynges of embryos at 8E–20E stages (in 2E and
4E embryos, PHA-4∷YFP photobleached too rapidly for analysis). PHA-
4∷YFP binding to the array appears as an intense YFP spot within a background
of weaker nuclear YFP expression (where PHA-4∷YFP binds to endogenous
targets). Images were merged in Photoshop, and YFP nuclear spots were
analyzed for co-localized CFP expression. In embryos designated positive, up to
4 co-localized nuclear spots were observed per slice. All co-localized spots were
exclusively observed in the pharynx. Two transgenic lines, 20 embryos each
line, were imaged for each control or target array.Results
Three experiments were performed to address the role of
pha-4 during pharyngeal development. First, by challenging
pharyngeal precursors with a heterologous regulator, we
established when pharyngeal precursors transfate to pharyngeal
fate. Second, to determine when pha-4 functions, we examined
whether pharyngeal cells were generated when pha-4 expres-
sion was reduced at different times in development. Third, we
examined whether pharyngeal cells could transfate to an
alternative cell type when pha-4 expression was reduced at
different developmental stages. These experiments defined the
4E–8E stages as a critical time for commitment to pharyngeal
fate and revealed that pha-4 activity is required for pharyngeal
cell fate specification at or before this time. pha-4 is also
required subsequently for pharyngeal differentiation and
morphogenesis.
4E–8E stages are a critical period for commitment to the
pharynx fate
To determine when pharynx precursors were committed to
pharyngeal fate, exogenous cell fate regulators were expressed
at different stages to challenge wild-type pharyngeal cells to
adopt alternate cell fates. Activation of gene expression by
heat shock is very rapid, providing an accurate means to
assess developmental timing (Fukushige and Krause, 2005;
Horner et al., 1998; Labouesse and Mango, 1999; Zhu et al.,
1998).
When induced by a heat shock (HS) promoter, the midgut
GATA transcription factor end-1, and the muscle bHLH
transcription factor hlh-1 transfate precursors to midgut and
muscle, respectively (Fukushige and Krause, 2005; Zhu et al.,
1998). To follow pharyngeal cell development specifically,
transcription of HS∷end-1 or HS∷hlh-1 was activated briefly
at the 2E, 4E, 8E, or 16E stages, and cell fates assayed after
overnight incubation. Terminal embryos were co-immunos-
tained for the pharyngeal marker PHA-4, and for one of thefollowing: the early midgut marker ELT-2, the late midgut
marker 1CB4, or the muscle marker 4C6.3 (Fig. 1). Although
PHA-4 is expressed in both midgut and pharyngeal cells
(Horner et al., 1998; Kalb et al., 1998), pharyngeal cells are
clearly distinguishable both by their stronger PHA-4 expression
relative to endodermal cells, and their lack of 1CB4 staining
(compare Figs. 1A, D).
The pharynx challenge revealed that most pluripotent
pharyngeal precursors become committed to pharyngeal fate
at the 4E-8E stages. When pharyngeal precursors were
challenged with HS∷end-1 at the 2E stage, all pharyngeal
precursors transfated in the majority of embryos. There was
ubiquitous expression of midgut markers and a lack of bright
PHA-4 stain (Figs. 1A–C, G–I). This finding is in agreement
with published results (Zhu et al., 1998). By contrast, when
challenged at the 4E stage, most embryos had a small number of
precursors that were refractory to the challenge and differen-
tiated as pharynx. This conclusion is based on the emergence of
bright PHA-4 staining at the expense of midgut marker
expression in subsets of cells (Figs. 1D–F, J–L). Embryos
challenged at the 8E stage had a larger complement of
precursors that were refractory to the challenge (Figs. 1M–O),
and embryos treated at the 16E stage were completely
unaffected by the challenge and appeared wild-type (data not
shown). Similar results were obtained when the pharyngeal
precursors were challenged to acquire body wall muscle fate
(Figs. 1P–U, data not shown).
These results were quantified to determine when precursors
commit to pharyngeal fate (Fig. 1V). When challenged to
become midgut at the 2E 4E, 8E, and 16E stages (n>65 each
stage), 18%, 64%, 91%, and 100% animals exhibited
pharyngeal cells, respectively. When challenged to become
muscle at the 2E, 4E, 8E, and 16E stages (n>20 each stage),
18%, 55%, 80% and 100% embryos exhibited pharyngeal cells,
respectively. In summary, at the 2E stage, a relatively small
percentage of embryos are unresponsive to exogenous devel-
opmental regulators. This may reflect initiation of commitment
to the pharynx fate, alternatively some embryos may have been
exiting the 2E stage at the time of heat shock. By the 4E stage,
more than half the embryos are refractory to cell fate change.
One cell division later, at the 8E stage, the vast majority of
embryos have pharyngeal cells, suggesting the window of
plasticity is largely complete.
pha-4 contributes to early and late pharyngeal development
To determine when pha-4 was required to establish pha-
ryngeal fate, pha-4 temperature-sensitive (ts) animals [smg-1
(cc546ts);pha-4(q500)] (Kaltenbach et al., 2005) were shifted
from permissive to restrictive temperature at incrementally later
stages (2E, 4E, 8E, 16E) and allowed to mature overnight.
Based on pharynx morphology using DIC microscopy (Figs.
2A–D), terminal embryos were placed into one of four
categories. Ranked from most to least severe, the categories
were: (1) “No detectable pharynx” (Fig. 2A), (2) “Pun” or
pharynx unattached, where pharynges failed to attach to the
mouth due to fewer pharyngeal cells or aberrant morphogenesis
Fig. 1. 4E–8E stages are a critical period for commitment to the pharynx fate. Pharyngeal precursors were challenged to adopt endodermal or muscle fates by activating
expression of (A–O) HS∷end-1, or (P–U) HS∷hlh-1, respectively. Embryos challenged at (A–C, G–I, P–R) 2E, (D–F, J–L, S–U) 4E and (M–O) 8E stages are
shown. (A, D, G, J, M, P, S) Embryos stained with anti-PHA-4. Midgut cells show weak PHA-4 expression, as expected. Pharyngeal bright PHA-4 stain does not co-
localize with gut or muscle markers, and is marked with dotted circles. Embryos stained with (B, E) the early endodermal marker, ELT-2, (H, K, N) the late endodermal
marker, 1CB4, and (Q, T) the muscle differentiation marker, paramyosin. (C, F, I, L, O, R, U) merge. (V) Graph shows percentage of embryos heat shock treated at the
2E, 4E, 8E, and 16E stages that exhibit pharyngeal cells. Embryos either bear HS∷end-1 (red) or HS∷hlh-1 (blue).
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clear morphological defects (Fig. 2C), and (4) “Wild-type”
where pharyngeal morphology appeared normal (Fig. 2D).
Control smg-1(ts) animals shifted at different embryonic stages
hadWild-type pharynges (n>15 each stage, data not shown).We
confirmed pharyngeal phenotypes by immunostaining for three
markers indicative of different cell types and developmental
stages: α-intermediate filament, 3NB12, and 9.2.1 label
marginal cells (Figs. 2E–H; (Pruss et al., 1981), early pharyngeal
muscle (Figs. 2I–L; (Priess and Thomson, 1987), and terminal,
differentiated pharyngeal muscle (Figs. 2M–P; (Miller et al.,
1983), respectively. As in pha-4 null embryos, “No pharynx”
embryos displayed trace amounts of cell-type specific markers
(Figs. 2E, I, M; (Mango et al., 1994a). Antibody staining of
“Pun”, “Misshapen”, or “Wild-type” embryos mirrored overall
pharyngeal morphology, demonstrating that the categories
accurately reflected the terminal phenotype.
Quantification of observed phenotypes (Fig. 2Q) demon-
strated that pha-4 was required first to specify pharyngeal
identity (Mango et al., 1994a) and subsequently to drive
morphogenesis/ differentiation. Under the most restrictive
conditions, when pha-4(ts) L4 stage animals developed to
adulthood and laid eggs at restrictive temperature, 60% (20/34)
of embryos had no pharynx, indicating that this strain could
mimic the pha-4 null phenotype. Similarly, a large proportion of
embryos shifted to restrictive temperature at the 2-cell stage hadNo pharynx (37%, 22/60). Embryos shifted at later stages
showed progressively less severe morphological phenotypes.
Of embryos shifted at the 2E (n=87), 4E (n=43), 8E (n=45),
and 16E (n=25) stages, the highest represented phenotypes
were Pun (2E, 76%), Misshapen (4E, 42%), and Wild-type (8E,
82%; 16E, 97%), respectively. The majority of Pun pharynges
observed among 2-cell and 2E shifted animals appeared
considerably smaller than wild-type pharynges (Compare
Figs. 2J, N, to 2L, P), consistent with the idea that fewer cells
were specified to the pharynx fate. These data suggest that pha-
4 activity is required by approximately the 4E stage to establish
the normal complement of pharyngeal precursors.
Conversely, shifting pha-4(ts) embryos from restrictive to
permissive temperature demonstrated that pha-4 must be active
within an early developmental window to rescue pharynx
development fully (Fig. 2R, Supplementary Figure 1). Only
embryos shifted to permissive temperature at the 2-cell (n=16),
and 2E (n=57) stages exhibited Wild-type pharyngeal mor-
phology (96% and 68%, respectively). Embryos shifted later
showed more severe morphologies. Most embryos shifted at the
4E stage (73%, n=41) were Pun with wild-type size pharynges
(Supplementary Figure 1B). A large proportion of embryos
shifted at the 8E stage (37%, n=38), and most shifted at the 16E
stage (79%, n=28), had No pharynx, and the majority of Pun
animals observed at these stages had small pharynges
(Supplementary Figure 1C). We conclude that re-activation of
Fig. 2. pha-4 is required for pharyngeal specification and morphogenesis/ differentiation. Representative phenotypes of pha-4(ts) embryos shifted from permissive to
restrictive temperature at different stages in development. (A, E, I, M) No pharynx phenotype, (B, F, J, N) pharynx unattached (Pun), (C, G, K, O) Misshapen pharynx,
(D, H, L, P) Wild-type pharynx morphology. Phenotypes were examined by morphology and expression of pharyngeal markers. (A–D) Differential interference
contrast (DIC) images, (E–H) α-intermediate filament antibody marks marginal cells, (I–L) 3NB12 antibody marks early (e) pharyngeal muscle, (M–P) 9.2.1 antibody
marks late (l) pharyngeal muscle. Arrows indicate buccal cavity; arrowheads outline edges of Pun and Misshapen pharynges; bracket and parenthesis indicate anterior
bulb, and posterior bulb, respectively. pha-4(ts) embryos shifted at 2-cell, 2E, 4E, 8E, 16E stages exhibit an array of pharyngeal phenotypes. (Q) Percentage of pha-4
(ts) embryos shifted from permissive to restrictive temperature with designated pharynx phenotypes (R) Percentage of pha-4(ts) embryos shifted from restrictive to
permissive temperature with designated pharynx phenotypes.
616 J.C. Kiefer et al. / Developmental Biology 303 (2007) 611–624pha-4 expression after the 4E stage is not sufficient to rescue
pharyngeal specification.
We reasoned that when cells are committed to the
pharyngeal fate, they should not be able to adopt an alternative
fate. We examined whether cells can adopt an alternative fate
when pha-4 activity is reduced at the 2-cell to 8E stages. We
focused on ectoderm since previous studies had shown that
pharyngeal precursors from pha-4 null animals can develop
into LIN-26+ ectoderm (Horner et al., 1998). pha-4(ts) embryos
were shifted to restrictive temperature and assayed for ectopic
expression of ectodermal markers LIN-26 and elt-3∷gfp in the
presumptive pharynx (Fig. 3). Early shifted animals exhibited
ectopic expression of LIN-26 (Fig. 3A) and the transgene
elt-3∷gfp (Fig. 3C) in the presumptive pharynx, whereas late
shifted animals did not (Figs. 3B, D). Specifically, pha-4(ts);
elt-3∷gfp embryos shifted at the 2-cell (n=26), 2E (n=23), 4E(n=28), and 8E (n=10) stages exhibited 62%, 27%, 13%, and
0% transfated cells, respectively (Fig. 3E). Therefore, only
animals shifted prior to the 8E stage exhibited ectopic
expression of ectodermal markers in the pharynx. Collectively,
these experiments suggest that pha-4 is required at the
Specification stage to establish the pharyngeal precursors.
After commitment to the pharyngeal fate, pha-4 is required for
Morphogenesis/Differentiation, based on the unusual morphol-
ogies of treated embryos.
PHA-4 binds the ectodermal gene lin-26 in pharyngeal cells
How does pha-4 regulate cell fate restriction? Previous
work from our lab showed that PHA-4 functions as a tran-
scriptional activator that promotes expression of pharyngeal
genes throughout development (Gaudet and Mango, 2002).
Fig. 4. Association of PHA-4∷YFP with lin-26 promoter. (A, E, I) PHA-4∷YFP (gre
with (B, F, J) LACI∷CFP (red) in a nuclear spot assay. (C, G, K) merged YFP and CF
arrays with co-localized PHA-4∷YFP and LACI∷CFP. (M) illustration of lin-2
(arrowheads) at sites of arrays with no target. (E–H) PHA-4∷YFP associates with tar
yellow overlap), (I–L) PHA-4∷YFP is not enriched (arrowheads) at sites of arrays
Fig. 3. Pharyngeal precursors are pluripotent in early development. pha-4(ts)
embryos shifted from permissive to restrictive temperature at the (A, C) 2E and
(B, D) 8E stages, and stained for the ectodermal markers (A, B) LIN-26 and (C, D)
elt-3∷gfp (closeup of head). Ectodermal LIN-26 and elt-3∷gfp is expressed
along the periphery of the embryo. Expression of ectodermal markers in
presumptive pharynx is indicated with dotted circles. Boundaries of pharynges are
marked with solid lines. (E) Proportion of pha-4(ts) embryos shifted from
permissive to restrictive temperature at the 2-cell, 2E, 4E, and 8E stages that
exhibit expression of the ectodermal marker, elt-3∷gfp in the pharynx.
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expression of the ectodermal gene, lin-26. First, pha-4 null
animals ectopically express LIN-26 in pharyngeal precursors
(Mango et al., 1994a). Second, widespread, ectopic expression
of PHA-4 promotes the pharyngeal fate at the expense of LIN-26
(Horner et al., 1998). Third, the lin-26 promoter bears multiple
consensus FoxA binding sites within a region containing several
blocks of sequence conserved with C. briggsae, called con-
served intron sequence (CIS) a–h (Dufourcq et al., 1999;
Landmann et al., 2004). GFP reporters made from promoter
fragments revealed that the CISe-i region, or lin-26 3′UTR,
bears sequences that prevent pharyngeal expression. Within
these regions, CISg (∼900 kb) has three consensus FoxA sites
(Landmann et al., 2004). Based on these observations, we
hypothesized that PHA-4 might repress lin-26 by binding to
CISg.
The nuclear spot assay (Carmi et al., 1998; Gonzalez-
Serricchio and Sternberg, 2006; Kaltenbach et al., 2000; Updike
and Mango, 2006) was used to determine whether PHA-4
associates directly with lin-26 CISg (Fig. 4). pha-4∷yfp and
lin-26 CISg DNAs were co-injected with lacI∷cfp and lacO to
generate an extrachromosomal array. LacI∷CFP binding to lacO
was visualized as a small CFP “spot” that marked the location of
the array in cell nuclei. In vivo binding of PHA-4∷YFP to target
promoters was visualized as a yellow spot that co-localized with
LacI∷CFP.
The nuclear spot assay shows that PHA-4∷YFP associates
with lin-26 CISg. In control animals with no target promoter in
the extrachromosomal array, a background of 15% of embryos
exhibited co-localized spots (2 strains, n=20 embryos each;en) is expressed in pharyngeal cells. Extrachromosomal target arrays are marked
P spots are yellow. (D, H, L) illustrations of target arrays, and proportion of target
6 promoter highlighting CISg region. (A–D) PHA-4∷YFP is not enriched
get arrays containing the ectodermal gene lin-26 promoter CISg (arrows indicate
containing lin-26 CISg with conserved FoxA binding sites mutated.
Fig. 5. tam-1 enhances pha-4. (A) Proportion of lethal L1 larvae observed in
tam-1(cc567), smg-1(0);pha-4, and smg-1(0);pha-4;tam-1(cc567) mutant
strains (B, C) Embryos subjected to weak pha-4(RNAi) and stained for the
ectodermal marker, LIN-26. Ectopic LIN-26 in presumptive pharynx marked
with arrows. (B) smg-1(0);pha-4, (C) smg-1(0);pha-4;tam-1(cc567). (D) N2
and (E) tam-1(cc567) 2-fold embryos at restrictive temperature (25°) stained
with anti-PHA-4.
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cryptic PHA-4 sites in co-injected DNA. We observed
PHA-4∷YFP binding to lin-26 CISg in approximately 50% of
pharynges in two independent lines (n=20 embryos each; Figs.
4E–H). Importantly, when the three FoxA binding sites in CISg
were mutated, the frequency of co-localized spots was reduced
to background levels (16%, 2 strains, n=20 embryos; Figs.
4I–L). These results demonstrate that PHA-4 associates with a
repressed, ectodermal target within the pharynx.
tam-1 cooperates with pha-4 to specify the pharyngeal cell fate
How does pha-4 function as a repressor? To begin to address
this question, we surveyed potential PHA-4 interacting proteins
for genes that enhance pha-4 lethality. The C. elegans
Interactome previously identified twelve proteins that interacted
with PHA-4 in a yeast two-hybrid study (Li et al., 2004). We
surveyed genes encoding each of the twelve candidate PHA-4
interacting proteins to determine if any could enhance a partial
loss of pha-4 function observed in smg-1(0);pha-4 animals
(Gaudet and Mango, 2002; Kaltenbach et al., 2005). Our
positive control F38A6.1 (pha-4), produced embryonic and
larval lethality in WT and smg(0);pha-4 strains as expected
(Supplementary Table 1; (Mango et al., 1994a). Of the
candidate PHA-4 interactors, only tam-1 had synthetic effects
with pha-4. tam-1(RNAi) of smg-1(0);pha-4 animals lead to
30% arrested progeny at the first larval (L1) stage (n=20,
Supplementary Table 1). Arrested L1s exhibited one of the
following pharyngeal defects: Pun, Misshapen pharynges, or
pharynges stuffed with bacteria, a sign of a malfunctioning
pharynx. By contrast, fewer than 5% of control smg-1(0);tam-1
(RNAi) or smg-1(0);pha-4 animals arrested at the L1 stage (data
not shown). These findings reveal that that tam-1 interacts with
pha-4 genetically.
We verified the genetic interaction between pha-4 and tam-1
in two ways. For these experiments we used tam-1(cc567),
which carries a nonsense mutation in tam-1 and behaves as a
null at restrictive temperature (Hsieh et al., 1999). First, we
found that smg-1(0);pha-4;tam-1(cc567) triple mutants exhib-
ited a 12-fold increase in synthetic embryonic/L1 lethality at
restrictive temperature compared to smg-1(0);pha-4 alone
(61±12% vs. 5±5% lethality), and a 20-fold enhancement
compared to tam-1(cc567) alone (61±12% vs. 3±2% lethality;
>100 embryos per trial, 3 trials, p-value ≤0.0001) (Fig. 5A).
Thus, the synergy that we saw did not depend on RNAi.
Second, weak pha-4(RNAi) was performed on tam-1(cc567)
animals at restrictive temperature by diluting bacteria producing
pha-4 double-stranded (ds) RNA with bacteria producing GFP
dsRNA. In 8/8 trials, tam-1(cc567) significantly enhanced
weak pha-4(RNAi) by an average of 2-fold (p-value=0.0138,
Supplementary Table 2). Thus, enhancement did not depend on
the smg-1 mutant allele. We note that enhancement values were
sometimes compressed due to lethality induced by weak pha-4
(RNAi) in control animals. For example, in one trial, weak pha-
4(RNAi) produced 48% lethality in control and 100% lethality
in tam-1(cc567) strains, thus producing the maximum enhance-
ment possible at 2.1-fold (Supplementary Table 3).Does tam-1 impact the Specification stage of pharyngeal
development? We examined the extent of cell fate transforma-
tions in either smg-1(0);pha-4 or smg-1(0);pha-4;tam-1(cc567)
embryos administered weak pha-4(RNAi). 33% of smg-1(0);
pha-4;tam-1(cc567) embryos exhibited ectopic LIN-26 expres-
sion in the presumptive pharynx (n=20), compared to 0% in
smg-1(0);pha-4 animals (n=20) (Figs. 5B, C). Control tam-1
(cc567); gfp(RNAi) animals did not display pharyngeal defects
or cell fate transformations (n=20, data not shown). To
determine whether tam-1 functions in pharyngeal specification
by regulating PHA-4 expression, wild-type (N2) and tam-1
(cc567) were raised at restrictive temperature and immunos-
tained with anti-PHA-4. PHA-4 expression is unchanged in
tam-1 animals compared to wild-type (Figs. 5D, E), demon-
strating that tam-1 is not required for PHA-4 expression. These
data support the notion that tam-1 functions with pha-4 to
regulate specification of pharyngeal cells.
NuRD components interact genetically with pha-4
In genetic tests, tam-1 behaves as a synMuv B gene (Hsieh et
al., 1999), suggesting that other synMuv genes might also
interact genetically with pha-4. TAM-1 contains a tripartite
motif (TRIM, or RBCC domain), consisting of RING finger, B-
box, and coiled-coil domains. Many TRIM domain proteins
mediate transcriptional repression (Frank and Roth, 1998;
Meroni and Diez-Roux, 2005; Peng et al., 2002; Wu et al.,
2001). Therefore, we focused our analysis on NuRD compo-
nents to test whether other mediators of transcriptional repres-
sion enhance pha-4.
Table 1
NuRD components enhance pha-4









pha-4 egl-27(n170) MTA-1 3.4 0.0372 3
egl-27 smg(ts); pha-4 19.0 0.0001 3
pha-4 egr-1(ku285) MTA-1 5.5 0.0003 3
egr-1 smg(ts); pha-4 4.6 0.0051 4
pha-4 chd-3(eh4) Mi-2 2.5 0.0093 5
pha-4 lin-53(n833) RbAp48 1.3 0.4497 3
lin-53 smg(ts); pha-4 1.2 0.0001 4
pha-4 chd-4(ar113) Mi-2 0.3 0.3360 3
mep-1 smg(ts); pha-4 CHD-4 interactor 1.7 1.000 3
synMuv B (control)
pha-4 lin-52(n771) novel 0.9 0.9261 3
Embryonic/L1 lethality was compared between smg(ts);pha-4 and smg(ts)
strains fed NuRD(RNAi), or between NuRD genetic mutants and wild-type
worms fed diluted pha-4(RNAi).
Fig. 6. NuRD components enhance pha-4. Embryos administered weak pha-4
(RNAi) and assayed for pharyngeal morphology by staining for adherens
junction marker MH27. (A) Control (WT), (B) pha-4(q490) null, (C) tam-1
(cc567), (D) chd-3(eh4). Arrowhead indicates buccal cavity, dotted line
indicates posterior end of pharynx. Intact midgut MH27 stain lies posterior to
the phaynx. (E) Percentage of embryos with pharyngeal phenotypes observed in
control [WT, lin-52(n771)] or tam-1 and NuRD mutant strains [tam-1(cc567),
chd-3(eh4), egl-27(n170)] fed weak pha-4(RNAi).
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inactivation of some NuRD components enhance pha-4
(Table 1, Supplementary Table 2, 3). First, weak pha-4(RNAi)
was performed on NuRD mutant strains, and progeny examined
for enhanced lethality. In this assay, three NuRD mutants, MTA/
egl-27(n170), MTA/egr-1(ku285) and Mi-2/chd-3(eh4), each
showed significant enhancement with pha-4 (p-value<0.05),
whereas Mi-2/chd-4(ar113) and RbAp48/lin-53(n833) did not.
In addition to tam-1 and NuRD, four synMuv B genes (lin-9,
lin-13, lin-54, ubc-9) and no synMuv A genes interacted
genetically with pha-4 (Supplementary Table 2). We have the
greatest confidence in genes that like tam-1, reproducibly
enhanced pha-4 with statistical significance, and therefore only
these were scored as enhancers. As lin-9 and lin-13 are reported
to augment RNAi (Lehner et al., 2006; Wang et al., 2005), we
cannot rule out RNAi effects for these two genes.
In the converse experiment, RNAi against NuRD compo-
nents egl-27, egr-1, lin-53 and mep-1 combined with loss of
function pha-4 worms, smg(ts);pha-4 at permissive temper-
ature, revealed significant enhancement by egl-27 and egr-1
(Table 1). Enhancement by lin-53 (1.2 average fold enhance-
ment, p-value .0001) may be compressed due to high lethality
induced by lin-53(RNAi) in control animals. For example in
one trial, lin-53(RNAi) produced 79% lethality in control and
99.5% lethality in smg(ts);pha-4 strains, thus producing the
maximum enhancement possible at 1.3-fold (Supplementary
Table 4). The observation that vulva development is parti-
cularly sensitive to the partial loss-of-function mutation lin-53
(n833), while embryonic roles are unaffected, may explain the
apparent discrepancy between results obtained with lin-53
(RNAi) and lin-53(n833) (Lu and Horvitz, 1998). Another
possibility is that since lin-53(RNAi) causes a high percentage
of lethality on its own, it could be non-specifically hyper-
sensitive to the reduction of a second gene. These findings
suggest that some NuRD components interact synergistically
with pha-4 mutations to control viability.
The enhancement of lethality between pha-4 and NuRD
reflected a failure to specify cells to the pharyngeal fate. Weused the adherens junction marker MH27 to show that 9%,
13%, and 25% of tam-1, Mi-2/chd-3(eh4), and MTA/egl-27
(n170) animals, respectively, did not develop pharynges when
combined with weak pha-4(RNAi) (Fig. 6; n>30 embryos per
strain (Francis and Waterston, 1991). Weak pha-4(RNAi) alone
with WT animals did not produce any pharynx-less embryos
(n=59) (Fig. 6A). Comparing egl-27 and chd-3 to negative
controls (WT and the synMuv B gene lin-52(n771) which does
not enhance pha-4 (Table 1), there was a 7- to 13-fold
enhancement of the No pharynx phenotype (Figs. 6C–E), and a
2- to 3-fold enhancement of the Pun phenotype (Fig. 6E).
Importantly, enhancement of pharyngeal phenotypes was
specific, since non-pharyngeal tissues appeared normal (for
example, compare Figs. 6A, C, right of dotted line). These data
show that MTA/chd-3, Mi-2/egl-27, and Mi-2/egr-1 affect
pharyngeal cell fate specification.
Taken together we find that Mi-2/egl-27, and Mi-2/egr-1,
enhance pha-4 by influencing cell fate specification whereas
MTA/chd-4 and mep-1 do not. Results with chd-3 could not
be confirmed due to the failure of controls; feeding and injecting
chd-3(RNAi) did not produce the Muv phenotype in lin-15A
(n767) animals (data not shown). As expected, in none of these
experiments did we observe a Muv phenotype when pha-4 loss-
of-function was combined with loss of synMuv components
(data not shown).
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A central question in developmental biology concerns how a
cell transitions from the pluripotent state to become a single,
differentiated cell type. Our findings reveal that the 4E–8E
stages are a critical period when early precursors of the C.
elegans pharynx lose their developmental plasticity and become
committed to the pharyngeal fate. This transition depends on the
selector gene pha-4, which cooperates with the TRIM protein
TAM-1 and components of the NuRD complex. tam-1 and pha-
4 are required to repress ectodermal genes within nascent
pharyngeal precursors. We suggest that PHA-4 functions as
both a transcriptional activator and a repressor to promote
pharyngeal fate and inhibit alternative fates.
Two stages of restriction for pharyngeal precursors
Three experiments indicate that pha-4 functions during the
2E (when expression initiates) to 8E stages to promote the
transition from a pluripotent to a committed developmental
state. First, when challenged with an exogenous selector gene,
the ability of most wildtype pharyngeal precursors to transfate
to endoderm or body wall muscle is lost between the 4E-8E
stages. Second, pharyngeal precursors transfate to ectoderm
when pha-4 is inactivated prior to the 8E stage. Third,
pharyngeal development in pha-4(ts) mutants can be rescued
only when pha-4 activity is restored before the 8E stage. We
note that transition from the pluripotent to the committed state
reflects commitment to pharyngeal identity, but not to a specific
cell type within the pharynx. Until the terminal cell divisions,
pharyngeal precursors exist that will generate distinct pharyn-
geal cell types, such as the gland cell g1AL (MSaaapaapaa) and
neurosecretory-motor cells NSML (ABaraapapaav) and NSMR
(ABaraapppaav) (Sulston et al., 1983). Thus, cells whose des-
cendents will become pharyngeal cells undergo at least two
stages of developmental restriction: first to a pharyngeal identity
at the 4E–8E stages (Specification stage) and subsequently to a
pharyngeal cell type (Morphogenesis/ Differentiation stage).
The timing we observe agrees well with the cell lineage, in
which blastomeres of the 4E–8E stages produce either
pharyngeal cells or non-pharyngeal cells, but not both (Sulston
et al., 1983). We note that although we observed the shift in
pha-4(ts) animals at approximately the 4E stage, the transition
was not precise. This effect could reflect a lag in knock-down of
pha-4 RNA and protein, a concern with any temperature-shift
experiment, or it could reflect a broad temporal requirement for
pha-4. Either way, our data suggest that pha-4 is required at the
Specification stage to establish pharyngeal precursors. Activa-
tion of gene expression by heat shock is rapid, therefore the
midgut and muscle challenge experiments accurately reflect the
timing of commitment to the pharyngeal fate.
Other studies have also implicated the∼ 4E–8E stages as the
transitional stage for developmental competence (Labouesse
and Mango, 1999). For example, ectopic expression of pha-4
throughout the embryo can convert a proportion of embryonic
cells to a pharyngeal fate, provided pha-4 is expressed prior to
the 4E stage (Horner et al., 1998). Similarly, widespread end-1or hlh-1 expression can induce embryonic blastomeres to
become intestine or body wall muscles, respectively, until the
4E–10E stages (Fukushige and Krause, 2005; Zhu et al., 1998).
We note that a previous study implicated that pharyngeal
precursors first became refractory to HS∷hlh-1 at the 10E stage
(Fukushige and Krause, 2005). One possible reason for the
observed difference compared to our work is that the marker for
pharynx fate in the previous study is expressed in fewer cells
(3NB12, in a subset of pharyngeal muscles) compared to the
marker used in this work (PHA-4), which is a global marker of
pharyngeal cells. Together these observations suggest that early
embryonic blastomeres are receptive to different selector genes
and can follow alternative developmental pathways during the
Specification stage, whereas older blastomeres lose pluripo-
tency while still retaining plasticity with regard to pharyngeal
cell type. However, because these studies relied on exogenous
regulators, the mechanisms guiding this transition during
normal development were mysterious.
Consistent with the 2E–8E stages representing a global
transition point in cell fate potential, genes that specify cell fates
are typically expressed at or before the 8E stage, including cell
fate regulators for pharynx (pha-4, see below), chemosensory
neurons (unc-130), mesendoderm (med-1/2), endoderm (end-
1/3), and ectoderm (elt-1) (Baugh et al., 2003; Horner et al.,
1998; Maduro et al., 2001; Sarafi-Reinach and Sengupta, 2000;
Spieth et al., 1991; Zhu et al., 1997). Genes that control terminal
differentiation generally initiate expression after the 4E stage,
for example differentiation genes of the ectoderm (elt-3),
pharyngeal muscle (ceh-22, myo-2), and endoderm (ges-1)
(Egan et al., 1995; Gilleard et al., 1999; Granato et al., 1994;
Jantsch-Plunger and Fire, 1994; Okkema and Fire, 1994). The
notable exception is the muscle gene, hlh-1, which initiates
expression at early 4E but affects muscle differentiation more
than fate in loss of function studies (Chen et al., 1992). This
observation may reflect that hlh-1, like its vertebrate ortholog
MyoD, has the additional capacity to behave like a specification
gene, and transform other cell types to muscle when mis-
expressed (Fukushige and Krause, 2005; Rudnicki et al., 1993).
These data support the notion that the C. elegans embryo is
organized temporally to specify cell fates and promote
differentiation during different phases of development.
Specification by PHA-4 involves both activator and repressor
functions
Our findings suggest that PHA-4 functions both positively
and negatively to restrict the developmental choices of
embryonic cells during specification of pharyngeal fate.
Previous work revealed that PHA-4, and its orthologs in
mammals and Drosophila, activate foregut gene transcription
directly (Gaudet and Mango, 2002; Liu et al., 2002; Mach et al.,
1996). Targets of PHA-4 or FoxA activation are likely to
contribute to cell fate choices. For example, pha-4 activates the
T-box factor tbx-2, which is required to generate pharyngeal
muscles from the embryonic blastomere, ABa (Smith and
Mango, in press). In vertebrates, FoxA2 directly activates the
signaling molecule sonic hedgehog, which is important to
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tional activation by FoxA proteins is critical for the cell fate
specification activities.
The data presented here suggest PHA-4 also functions as a
transcriptional repressor to block an alternative ectodermal
fate. Loss of pha-4 activity leads to expression of the
ectodermal genes, lin-26 (Horner et al., 1998) and elt-3 (this
work) within cells that would normally acquire a pharyngeal
fate. Conversely, ectopic expression of pha-4 throughout the
embryo silences expression of the ectodermal regulator lin-26
(Horner et al., 1998). The lin-26 CISg regulatory element is
peppered with consensus, conserved PHA-4 sites (Landmann
et al., 2004). Here, we show that PHA-4 associates with the
CISg regulatory element within pharyngeal cells, suggesting
direct repression by PHA-4. We note that mutation of the CISg
pha-4 consensus sites in a lin-26∷gfp transgene bearing the
CISg-i elements is not sufficient to eliminate repression of
transgene expression in pharyngeal cells (data not shown).
PHA-4 may also bind additional consensus sites that are
present in this region (Landmann et al., 2004).
The notion that FoxA proteins may be repressors has been
suggested by Davidson and colleagues. In sea urchin embryos,
foxa prevents foxb and brachyury (bra) from being expressed in
the anterior archenteron. In embryos where foxa expression is
blocked with morpholinos, expression of a bra cis-regulatory
construct spreads to the anterior archenteron (Davidson et al.,
2002). However, it has been unclear whether foxa represses bra
directly or whether foxa activates a repressor of bra. Our work
supports the idea that FoxA factors can function as transcrip-
tional repressors.
There is evidence that like pha-4, other selector genes
function as both activators and repressors. pax-6, a master
regulatory gene for the eye, activates numerous genes that are
essential for eye development, and also directly represses β1-
crystallin and δ1-crystallin (Duncan et al., 1998; Muta et al.,
2002; Ogino and Yasuda, 2000). Also, MyoD, a selector gene
for skeletal muscle, both activates and represses muscle-
specific genes (Tapscott, 2005). Prior to muscle differentia-
tion, MyoD recruits HDAC to repress myogenin expression.
During differentiation, HDAC is replaced with the acetyl-
transferase P/CAF, and MyoD activates myogenin transcrip-
tion (Mal and Harter, 2003). Most strikingly, there are
examples where these transcription factors function as
activators and repressors at the same time, in the same
cells. The NFKB-related protein Dorsal, activates short
gastrulation (sog) and represses zerknullt (zen) in the same
set of cells to pattern the presumptive Drosophila neuroecto-
derm (Stathopoulos and Levine, 2002). Similarly, the selector
gene GATA-1 controls hematopoietic development using both
activator and repressor functions (Crispino, 2005). Our data
suggest that like Dorsal and GATA-1, PHA-4 simultaneously
functions as an activator and repressor in the same cells.
Analysis of pha-4(ts) animals suggests pha-4 represses
ectodermal gene expression around the 2–4E stage. PHA-4
also functions as an activator at this time, for example, to
activate tbx-2 within a subset of pharyngeal cells (Smith and
Mango, in press). This bi-modal strategy may ensure thatcells acquire the appropriate cell fate and that they do not
express intermediate fates.
pha-4 interacts with tam-1 to repress the ectodermal fate
The means by which FoxA transcription factors function to
regulate gene transcription is not well understood in any organ-
ism. In vitro studies from Zaret and colleagues have suggested
that FoxA proteins bind compacted chromatin and modify the
chromatin environment to facilitate additional transcription
factor–DNA interactions (Cirillo et al., 2002; Shim et al., 1998).
However, it is currently unclear whether FoxA performs these
tasks alone or in combination with co-factors.
Our data show that pha-4 works in combination with tam-1
to inhibit the ectodermal cell fate. Of twelve candidate
interactors, tam-1 was the only gene to dramatically enhance
the lethality of weak pha-4 configurations and lead to
pronounced increases in ectopic ectodermal cells (this work).
Moreover, TAM-1 physically interacts with PHA-4 in a yeast
two hybrid screen (Li et al., 2004). Unfortunately, TAM-1
antibodies are no longer available, and translational TAM-
1∷GFP reporter constructs fail consistently (J. Hsieh, A. Fire,
personal communication, our unpublished observations), which
precluded an analysis of possible PHA-4–TAM-1 biochemical
interactions. Although we could not test for physical interac-
tions, the genetic interactions we observed are consistent with
PHA-4 interacting with TAM-1 in some capacity to repress
ectodermal genes such as lin-26.
How might TAM-1 and PHA-4 function? tam-1 was ori-
ginally identified in a screen for genes that, when mutated, lead
to silencing of extrachromosomal arrays bearing repetitive
elements (Hsieh et al., 1999). This phenotype could reflect an
activator function for TAM-1. Alternatively, TAM-1 could be
involved in repression, and loss of tam-1 activity could lead to
relocalization of repressors from the endogenous location to
ectopic sites such as repetitive extrachromosomal arrays.
Similar models have been proposed for the mes-4 methyl-
transferase (Garvin et al., 1998). This model implicates tam-1 in
targeting of repressors to the appropriate location, rather than
providing actual repression activity per se.
As a TRIM protein, TAM-1 may mediate transcriptional
repression. Many TRIM/RING finger proteins downregulate
gene transcription, possibly as ubiquitin ligases (Meroni and
Diez-Roux, 2005). The TRIM protein TIF1α and the RING
finger protein PML repress transcription by binding to the
Kruppel associated box protein (KRAB1) and to HDAC1,
respectively (Peng et al., 2002; Wu et al., 2001). In C. elegans,
ncl-1 encodes a TRIM-like protein that is required to repress
ribosomal RNA synthesis (Frank and Roth, 1998). An
appealing model to be tested in future studies is that PHA-4
recruits TAM-1 to ectodermal promoters in pharyngeal cells. An
alternative possibility is that tam-1 functions in parallel with
pha-4 to repress ectodermal genes.
Surprisingly, tam-1 mutants are viable with normal pharyn-
ges, whereas pha-4mutants arrest as embryos or larvae that lack
a pharynx. Two alternative explanations could account for the
subtlety of tam-1 mutant phenotypes. First, there are many
622 J.C. Kiefer et al. / Developmental Biology 303 (2007) 611–624TRIM proteins, and perhaps these are redundant for pharynx
development. Second, perhaps the activator function of PHA-4
and the activities of the targets activated by PHA-4 are sufficient
for pharynx development under normal circumstances. Only
when PHA-4 is compromised is the dependency for tam-1
activity revealed.
We found that two NuRD components tested for a role in
pharyngeal specification, Mi-2/chd-3 and MTA/egl-27, phe-
nocopied tam-1 and enhanced phenotypes associated with this
early role for pha-4. In addition, NuRD repressor complex
components MTA/egl-27, and MTA/egr-1 dramatically en-
hanced lethality of weak pha-4 configurations (predicted
NuRD components RbAp48/rba-1 and the HDAC hda-1 are
embryonic lethal and thus were not analyzed in our assays).
Therefore, we postulate that TAM-1 may recruit the NuRD
complex to regulate pha-4 targets. Intriguingly, other proteins
bearing a TRIM motif or just the RING finger domain mediate
transcriptional repression via binding to the NuRD subunit
Mi-2. The transcriptional repressor activity of KAP1 in vitro
depends on Mi-2α/CHD3 binding to its TRIM domain (Schultz
et al., 2001). The RING Finger Protein (RFP) also mediates
transcriptional repression by directly associating with Mi-2α
(Shimono et al., 2003). These observations suggest that TRIM/
RING finger proteins may exert their effects on transcriptional
repression via association with the NuRD complex.
We detected interactions between pha-4 and members of the
synMuv pathway. One phenotype associated with synMuv B
genes is augmentation of RNAi. However, the effects we
detected did not track with the strength of RNAi. For example,
tam-1 does not enhance RNAi (Lehner et al., 2006; Wang et al.,
2005) yet it had a pronounced effect on pha-4. Conversely, lin-
35 and dpl-1 had dramatic effects on RNAi (Lehner et al., 2006;
Wang et al., 2005) but no synergy with pha-4. Thus, the effects
we observed did not reflect indirect effects of RNAi for many of
the genes. For two genes we cannot rule out RNAi effects:
mutations in lin-9/Tudor and lin-13/C2H2 are reported to
augment RNAi (Lehner et al., 2006; Wang et al., 2005) and also
enhanced pha-4(RNAi). This interaction may reflect an indirect
influence of synMuv genes on RNAi efficiency. Finally, ubc-9,
an E2 ubiquitin ligase that mediates covalent attachment of
small ubiquitin-related modifier (SUMO) (Boulton et al., 2002)
also enhances pha-4 in our assays. There are two possibilities
to explain enhancement by the sumoylation pathway. First, the
TRIM motif found in TAM-1 is characteristic of E3 ubiquitin
ligases, suggesting that TAM-1 and UBC-9 may be part of the
same pathway. Alternatively, SUMO interacts with the pha-4
target tbx-2, and a strong SUMO loss of function has a pharynx
phenotype (Roy Chowdhuri et al., 2006). It remains to be
determined whether pha-4 utilizes sumoylation to regulate
target genes.
Recent reports have shown that inactivation of many
synMuv genes, including some NuRD components, leads to
ectopic lag-2 expression (Poulin et al., 2005). The lag-2 locus
encodes a ligand for Notch signaling, suggesting the
phenotypes associated with synMuv inactivation reflect excess
Notch signaling. In Drosophila, Notch signaling promotes
ectodermal epithelial fates, which could theoretically explainthe excess ectoderm in pha-4;tam-1 double mutants. However,
this explanation cannot account for the interactions we detect
between pha-4 and synMuv genes. For example, both mep-1
and lin-35 lead to ectopic lag-2 expression while egr-1 does
not (Poulin et al., 2005). Yet egr-1, but not mep-1 or lin-35,
enhances pha-4 loss-of-function mutations. We also note that
Notch signaling in the embryo induces pharyngeal develop-
ment and has not been shown to promote ectodermal cell fates
(Schnabel and Priess, 1997). Thus, in C. elegans, there is no
reason a priori to suspect excess Notch signaling would lead
to loss of the pharyngeal fate. Rather, an intriguing model is
that NuRD and tam-1 co-operate with pha-4 to repress
ectodermal genes and thereby promote specification to
pharyngeal fate.
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